Charcot-Marie-Tooth Disease Type 1C (CMT1C)

Charcot-Marie-Tooth disease type 1C (CMT1C) is a rare, inherited nerve disease. It mainly affects the long nerves that control movement and feeling in the feet, legs, hands, and arms. In CMT1C, a faulty gene called LITAF (also called SIMPLE) changes the way nerve-supporting cells (Schwann cells) handle certain proteins. This causes damage to the myelin coating around nerves. Over time, the damaged myelin slows nerve signals, leading to weakness, muscle wasting, foot deformities, and balance problems. CMT1C is usually mild to moderate and often starts in childhood or early adult life. There is no cure yet, but many treatments can reduce symptoms and prevent complications. PubMed+2molbiolcell.org+2

Charcot-Marie-Tooth disease type 1C (CMT1C) is a rare, inherited nerve disease that mainly affects the peripheral nerves. These are the long nerves that carry signals from the spinal cord to the arms, legs, hands, and feet. In CMT1C, a change (mutation) in a gene called LITAF (also called SIMPLE) damages the myelin sheath, which is the “insulation” around the nerve fibers. When myelin is damaged, nerve signals travel more slowly or get blocked. Over time, this causes weakness and wasting of the muscles, especially in the feet and lower legs, and later sometimes in the hands. CMT1C is usually slowly progressive and often starts in childhood or teenage years. It is inherited in an autosomal dominant way, which means a person can develop the disease if they inherit one changed copy of the gene from either parent.

Other names

Charcot-Marie-Tooth disease type 1C belongs to a large group of conditions called Charcot-Marie-Tooth disease. Doctors and researchers may use several different names or codes for the same disorder. CMT1C can be called hereditary motor and sensory neuropathy type 1C, because it affects both movement (motor) and feeling (sensory) in the limbs. It may also be grouped under demyelinating Charcot-Marie-Tooth disease, because its main problem is damage to the myelin sheath. Sometimes it is described as LITAF-related CMT or SIMPLE-related CMT, linking it directly to the responsible gene. All of these names refer to the same type of inherited peripheral neuropathy, just using different systems of classification or focusing on different features such as the gene, the pathology, or the clinical pattern.

Types and classification of CMT1C

CMT1C itself is a subtype of Charcot-Marie-Tooth type 1 (CMT1), which is the group of CMT disorders where the main problem is demyelination of peripheral nerves. Within CMT1, there are several types such as CMT1A, CMT1B, CMT1C, CMT1D, and others, each linked to a different gene. CMT1C is defined by disease-causing variants in the LITAF (SIMPLE) gene. It is considered a demyelinating neuropathy, because nerve conduction studies show slow conduction speed. CMT1C can also be grouped by how it appears in families, and it usually follows an autosomal dominant inheritance pattern. Even within CMT1C, there can be variation in severity and age at onset, but this variation does not form strict “types”; instead, doctors speak about milder, moderate, or more severe cases based on symptoms and disability level.

Causes and contributing factors

In medical science, the main true cause of CMT1C is a mutation in the LITAF (SIMPLE) gene. However, many factors can influence how the disease appears and how severe it becomes. Below are 20 detailed points, starting with the core cause and then describing related or contributing factors.

1. LITAF (SIMPLE) gene mutation
   The basic and main cause of CMT1C is a harmful change (pathogenic variant) in the LITAF gene. This gene normally helps control how certain proteins are broken down inside cells, especially in Schwann cells, which make myelin. When LITAF is mutated, the protein does not work properly. This leads to abnormal handling of proteins and damage to the myelin sheath in peripheral nerves. Over time, this causes slower nerve conduction, muscle weakness, and sensory loss.

2. Autosomal dominant inheritance
   CMT1C is inherited in an autosomal dominant pattern. This means a person can get the disease if they receive one mutated copy of the LITAF gene from either parent. Each child of an affected parent has a 50% chance of inheriting the mutation. This pattern of inheritance is not a separate cause, but it explains why the condition runs strongly in families and why several family members in different generations may have similar symptoms.

3. De novo (new) mutation
   Sometimes, the LITAF mutation appears for the first time in a child, even though neither parent has the mutation in their blood. This is called a de novo mutation. It happens because of a random change in the gene during the formation of egg or sperm cells, or early in the embryo. Although rare, this explains CMT1C in families with no known history of the disease.

4. Abnormal protein processing in Schwann cells
   The LITAF protein helps move certain proteins to the right place inside the cell, especially toward lysosomes, which are the “recycling centers.” When LITAF is faulty, these proteins may build up or be misrouted. In Schwann cells, this disturbed protein handling leads to stress inside the cell and damage to myelin. This cellular problem is a key step linking the gene mutation to nerve damage and symptoms.

5. Myelin sheath damage and demyelination
   Because Schwann cells are affected, the myelin they produce is abnormal or unstable. Over time, patches of myelin can break down, a process called demyelination. Demyelinated segments conduct electrical signals much more slowly, and sometimes the nerve fiber under the myelin can also be harmed. This demyelination is a direct cause of nerve conduction slowing seen in CMT1C.

6. Secondary axonal damage
   After long-lasting myelin damage, the underlying nerve fiber (axon) can also be injured. Axonal loss leads to fewer functioning nerve fibers. When many axons are damaged or lost, muscle weakness and wasting become more marked, and sensation (such as touch and vibration) becomes more reduced. This secondary axonal damage contributes to the progressive nature of CMT1C.

7. Genetic background and modifier genes
   Different people with the same LITAF mutation can have different levels of symptoms. One reason is that other genes in the person’s DNA, called modifier genes, may worsen or soften the effect of the main mutation. These genes might influence how cells handle stress, repair myelin, or maintain axons. This genetic background does not cause CMT1C by itself, but it can modify severity and age at onset.

8. Environmental nerve stress (repetitive trauma)
   Although the disease is genetic, environmental factors may worsen nerve injury. Repetitive trauma to the feet or ankles, such as heavy physical work, long-distance running on hard surfaces, or frequent sprains, can put extra stress on already fragile nerves. Over years, this may accelerate weakness or deformities, even though it does not cause CMT1C on its own.

9. Metabolic stress (for example, poorly controlled diabetes)
   If a person with CMT1C also develops diabetes, particularly if blood sugar is poorly controlled, the nerves may suffer extra damage from diabetic neuropathy. This combination can make symptoms worse and appear earlier. Diabetes is not a cause of CMT1C, but it can be a strong aggravating factor.

10. Nutritional deficiencies (for example, vitamin B12)
    Severe and long-lasting lack of certain vitamins, such as vitamin B12, can damage nerves. In someone who already has CMT1C, these deficiencies may worsen numbness and weakness. Again, vitamin deficiency does not cause the LITAF mutation, but it can add another layer of nerve injury.

11. Alcohol toxicity
    Heavy and long-term alcohol use can cause a toxic neuropathy. For a person with CMT1C, alcohol-related nerve toxicity may worsen symptoms, increase pain, and speed up disability. This is why doctors often recommend limiting or avoiding heavy alcohol intake in people with inherited neuropathies.

12. Exposure to neurotoxic drugs
    Some chemotherapy drugs and other medications are known to damage peripheral nerves. When a person with CMT1C receives such drugs, their already vulnerable nerves can be harmed more easily. This may lead to a sudden decline in strength or sensation. Doctors try to choose safer treatment options when possible for people with CMT.

13. Obesity and mechanical stress
    Being very overweight increases mechanical load on the feet and ankles. In someone with weak foot and leg muscles from CMT1C, this extra load can worsen foot deformities, pain, and walking problems. Obesity also raises the risk of other conditions like diabetes, which can further damage nerves.

14. Lack of physical activity
    When muscles are weak, people may move less. However, long-term lack of use can cause extra muscle wasting and joint stiffness, known as deconditioning. In CMT1C, where nerves are already damaged, deconditioning becomes another factor that increases disability. Carefully planned exercise is often advised to protect against this.

15. Poorly fitted footwear
    Shoes that do not support the arch and ankle or that squeeze the toes can worsen foot deformities like high arches and hammer toes. In CMT1C, where foot muscles are weak and imbalanced, poor footwear can lead to more pain, calluses, and instability, increasing the risk of falls and injuries.

16. Recurrent ankle sprains and falls
    Because foot drop and ankle weakness are common in CMT1C, people may have frequent ankle sprains. Each sprain can damage ligaments and joints. Over years, this repeated trauma can worsen deformities, pain, and walking problems, acting as an additional cause of disability.

17. Joint contractures and stiffness
    When muscles are weak and unbalanced, joints may slowly stiffen into fixed positions, called contractures. For example, toes may curl and stay in a clawed shape. These contractures are secondary problems but can greatly limit function, adding to the primary nerve damage.

18. Age-related nerve changes
    As people age, even healthy nerves show some decline in function. In a person with CMT1C, this normal age-related change adds on top of the existing neuropathy. Older people with CMT1C may therefore experience more rapid worsening of symptoms compared with younger adults with the same mutation.

19. Infections or severe illness
    Serious infections or illnesses that cause long periods of bed rest can lead to extra muscle wasting and weakness. In CMT1C, recovery of strength after such events can be slower and incomplete, so the person may notice a lasting decline in function.

20. Psychological stress and coping difficulties
    While psychological stress does not damage myelin directly, chronic stress, depression, or anxiety can reduce energy, sleep quality, and motivation to exercise or follow medical advice. This can indirectly worsen disability in CMT1C. Good mental health care and social support can therefore help people cope better with their symptoms and maintain activity.

Symptoms and signs

1. Slowly progressive weakness in the feet and lower legs
   One of the most common symptoms of CMT1C is weakness in the muscles that move the feet and ankles. This usually starts in childhood or teenage years and gets worse slowly over many years. People may notice they walk more slowly, tire easily when climbing stairs, or have trouble running. This weakness is due to poor nerve supply to the muscles because of demyelination and axonal loss.

2. Foot drop and tripping
   Because the muscles that lift the front of the foot become weak, the person may not be able to raise the foot fully when walking. This is called foot drop. As a result, the toes can catch on the ground, causing frequent tripping or falls. To avoid this, many people develop a high-stepping gait, lifting the knees higher than normal when they walk.

3. High-arched feet (pes cavus)
   CMT1C often causes an imbalance between different muscle groups in the foot. Some muscles become weaker, while others remain stronger, pulling the foot into an abnormal shape. A common deformity is high-arched feet, where the middle part of the foot is very high off the ground. This can cause pain, difficulty finding comfortable shoes, and more pressure on the ball and heel of the foot.

4. Hammer toes or claw toes
   Weakness and imbalance of the small muscles in the feet can also cause the toes to bend in an abnormal way. In hammer toes, the middle joint of the toe bends downward. In claw toes, the toes curl under. These deformities can cause calluses, pain, and trouble with shoe fit.

5. Wasting (atrophy) of lower leg muscles
   Because nerves are not working normally, muscles in the lower legs gradually shrink and lose bulk. This is called atrophy. The legs may appear thin below the knees, sometimes described as an “inverted champagne bottle” appearance. Muscle wasting makes weakness worse and reduces endurance for walking and standing.

6. Weakness in the hands and forearms
   As the disease progresses, the nerves supplying the hands can also be affected. This can cause weakness in the small muscles of the hands and, later, in the forearms. People may find it harder to grip objects, write, button clothes, or perform fine tasks. Hand weakness usually appears after leg symptoms but may vary between individuals.

7. Numbness and reduced sensation in the feet
   CMT1C affects sensory nerves as well as motor nerves. People often feel numbness, tingling, or “pins and needles” in their feet. They may have reduced ability to feel light touch, vibration, or temperature. This loss of sensation increases the risk of unnoticed injuries, blisters, or pressure sores on the feet.

8. Reduced or absent reflexes
   In a normal exam, tapping certain tendons causes a quick muscle jerk called a reflex. In CMT1C, reflexes, especially at the ankles, are often weak or absent. This happens because the nerve pathway that carries the reflex signal is damaged. Reduced reflexes are an important clue to nerve disease for doctors.

9. Balance problems and unsteady gait
   Loss of sensation in the feet and weakness in the legs make it hard to know the exact position of the feet and to control them. This can lead to poor balance, especially in the dark or on uneven ground. Many people with CMT1C feel unsteady, sway when standing with eyes closed, or need to hold railings on stairs.

10. Fatigue and easy tiredness
    Because the muscles are weak and less efficient, daily tasks require more effort. Walking, standing, or using the hands for long periods may cause early fatigue. People with CMT1C often feel more tired than others after similar activities, and they may need more frequent rest breaks.

11. Neuropathic pain or discomfort
    Some people with CMT1C experience pain, burning, or electric-like sensations in their feet and legs. This is called neuropathic pain and is caused by damaged nerves sending abnormal signals. Others may feel deep aching pain from strained joints and muscles due to abnormal gait and posture. Pain levels vary widely between individuals.

12. Cold or discolored feet
    Because of poor nerve function and sometimes reduced blood flow, the feet may feel cold or may look paler or slightly bluish compared with the rest of the body. While this is usually not dangerous, it can be uncomfortable and indicates poor nerve and blood supply in the extremities.

13. Difficulty running and participating in sports
    Children and teenagers with CMT1C often notice they cannot run as fast or jump as high as their friends. They may avoid sports that require quick footwork or balance. This difficulty in sports is often one of the first signs that leads families to seek medical advice, especially when combined with frequent tripping or ankle sprains.

14. Hand clumsiness and problems with fine motor tasks
    When hand involvement develops, people may drop objects more often, struggle with handwriting, or find it harder to perform tasks like threading a needle, tying shoelaces, or fastening small buttons. These problems can affect school work, job tasks, and daily living activities.

15. Emotional and social impact
    Living with a chronic, inherited nerve disease can affect mood and social life. Children may feel different from their peers. Adults may worry about passing the disease to their children or about their ability to work. Anxiety, low mood, or frustration can occur, especially if pain and disability increase. Emotional symptoms are not directly caused by nerve damage, but they are real and important parts of the illness experience.

Diagnostic tests

Physical examination

1. General neurological examination
   The first step in diagnosing CMT1C is a careful neurological exam by a doctor. The doctor looks at muscle bulk, checks strength in different muscle groups, tests reflexes with a reflex hammer, and examines sensation in the feet, legs, hands, and arms. They observe how the person walks and stands. In CMT1C, the exam often shows distal weakness, muscle wasting below the knees, high-arched feet, reduced or absent ankle reflexes, and decreased sensation. This pattern suggests a chronic, inherited peripheral neuropathy.

2. Gait observation and analysis
   The doctor watches the person walk across the room, turn, and possibly walk on heels and toes. In CMT1C, gait may show foot drop, high-stepping pattern, ankle instability, and difficulty walking on heels. Gait analysis helps the doctor understand how weakness and deformities affect movement and helps plan physical therapy and orthotic support.

3. Testing balance and coordination (Romberg test)
   To test balance, the person is asked to stand with feet together and then close their eyes (Romberg test). People with CMT1C may sway more or feel unstable because they rely heavily on visual cues to compensate for poor sensation in their feet. This test helps show how sensory loss affects balance.

4. Muscle strength testing with manual resistance
   The doctor applies resistance with their hands to different muscles, asking the person to push or pull. They score strength on a standard scale. In CMT1C, weakness is usually greater in the muscles that lift the feet and toes and in the small muscles of the hands. Manual strength testing gives a detailed picture of which muscle groups are affected and how severely.

5. Assessment of foot deformities and joint range of motion
   The doctor examines the shape of the feet, looking for high arches, hammer toes, or other deformities. They gently move the ankle, toe, and knee joints through their full range to check for stiffness or contractures. In CMT1C, they often find reduced ankle flexibility and fixed toe deformities. This assessment helps decide if orthotics or surgery might be needed.

Manual and functional tests

6. Timed walking tests (for example, 10-meter walk test)
   A timed walking test measures how long it takes to walk a set distance, such as 10 meters. This simple test gives an objective measure of walking speed and stability. In CMT1C, walking may be slower and less steady than normal. Repeating this test over time can show whether the disease is stable or worsening.

7. Grip strength measurement with a hand dynamometer
   To assess hand function, the clinician may use a device called a hand dynamometer to measure grip strength. The person squeezes the handle as hard as they can. In CMT1C with hand involvement, grip strength is reduced compared with healthy people of the same age and sex. Tracking grip strength helps monitor disease progression and the effect of therapy.

8. Functional scales for neuropathy (for example, CMT Examination Score)
   Doctors sometimes use standardized rating scales, such as the Charcot-Marie-Tooth Examination Score (CMTES), to grade symptoms and signs. These scales summarize information about strength, sensation, reflexes, and function into a numerical score. In CMT1C, the score tends to increase slowly over time as symptoms worsen, helping to monitor disease and response to treatments in research.

Laboratory and pathological tests

9. Routine blood tests to rule out other causes of neuropathy
   Although CMT1C is genetic, doctors usually perform basic blood tests to rule out other treatable causes of neuropathy. These may include tests for blood sugar, vitamin B12 levels, thyroid function, kidney and liver function, and tests for autoimmune disease. In pure CMT1C, these tests are usually normal, but they are important to be sure that no additional, fixable problem is present.

10. Genetic testing for LITAF (SIMPLE) mutations
    Definitive diagnosis of CMT1C relies on genetic testing. A blood sample is taken, and DNA is analyzed to look for disease-causing variants in the LITAF gene. Today, this is often done as part of a wider gene panel for peripheral neuropathy or CMT. Finding a pathogenic LITAF variant in a person with the right symptoms confirms the diagnosis and allows family testing and genetic counseling.

11. Extended genetic panels or exome sequencing
    If initial testing does not clearly find a mutation, or if the clinical picture is complex, doctors may order broader tests such as a large neuropathy gene panel or whole exome sequencing. These tests look at many genes at once. In some cases, they may reveal rare or new LITAF variants or show that another gene is responsible, which can redirect the diagnosis to another CMT subtype.

12. Nerve biopsy (rarely used now)
    In the past, doctors sometimes removed a small piece of nerve, usually from the ankle area, for microscopic study. This is called a nerve biopsy. In demyelinating CMT, biopsy can show features such as thin myelin and “onion bulb” formations created by repeated demyelination and remyelination. However, because genetic tests are now widely available and less invasive, nerve biopsy is used much less often and is usually reserved for unclear cases.

Electrodiagnostic studies

13. Nerve conduction studies (NCS)
    Nerve conduction studies involve placing small electrodes on the skin over nerves and muscles and giving tiny electrical pulses. The machine measures how fast and how strong the responses are. In CMT1C, nerve conduction velocities in motor and sensory nerves are slow, showing a demyelinating pattern. The amplitudes (size) of the responses may also be reduced if there is axonal loss. NCS are very important to distinguish demyelinating CMT1 from axonal CMT2.

14. Electromyography (EMG)
    Electromyography uses a fine needle inserted into muscles to record their electrical activity at rest and during contraction. In CMT1C, EMG often shows signs of chronic denervation, such as large motor units and reduced recruitment of muscle fibers. EMG helps confirm that weakness is due to nerve damage, not primary muscle disease, and provides extra information when nerve conduction studies are abnormal.

15. Repetitive nerve stimulation (if needed)
    Sometimes, doctors use repetitive nerve stimulation to check for problems at the neuromuscular junction, like myasthenia gravis, which can also cause weakness. In CMT1C, this test is usually normal. A normal repetitive stimulation study helps rule out other conditions and supports the diagnosis of a purely neuropathic process.

Imaging

16. Magnetic resonance imaging (MRI) of peripheral nerves or spine
    MRI can be used to look at peripheral nerves, muscles, and the spine. In some people with CMT, MRI may show thickened nerves or changes in muscle tissue such as fatty replacement. While MRI is not always necessary for diagnosis, it can help rule out other causes of neuropathy, such as nerve root compression or tumors, and may be used in research to better understand disease changes.

17. Ultrasound imaging of peripheral nerves
    High-resolution ultrasound can show the size and structure of peripheral nerves in the arms and legs. In demyelinating CMT, nerves may appear enlarged. Ultrasound is painless and quick, and it can help differentiate inherited neuropathies from acquired ones. In CMT1C, nerve ultrasound is not always done, but it can add supporting evidence of a diffuse neuropathic process.

18. Foot and ankle X-rays
    Plain X-rays of the feet and ankles can show bone alignment, high arches, hammer toes, and other deformities caused by chronic muscle imbalance. These images are useful for planning orthotic devices or surgeries and for monitoring changes in foot structure over time. In CMT1C, X-rays often show characteristic bony changes associated with long-standing neuropathy.

19. Spine X-ray or MRI for scoliosis (if suspected)
    Some people with CMT develop curvature of the spine (scoliosis). If scoliosis is suspected on exam, X-ray or MRI of the spine may be ordered. Imaging helps measure the curve and plan treatment, such as bracing or surgery in severe cases. While scoliosis is not specific to CMT1C, its presence can influence overall management.

20. Functional imaging or advanced research imaging (rare, research use)
    In some research settings, advanced imaging methods such as diffusion tensor imaging of nerves or detailed muscle MRI are used to study the structure and function of peripheral nerves and muscles in CMT. These methods are not routinely used in everyday clinical care, but they help scientists understand disease mechanisms and progression and may contribute to future treatments.

---

Goals of treatment in CMT1C

For CMT1C, treatment does not fix the gene problem. Instead, care focuses on helping you move better, stay active, reduce pain, and protect joints, feet, and nerves for as long as possible. Doctors and therapists use exercise, braces, safe shoes, and pain treatments to keep independence in walking, using hands, studying, and working. Regular follow-up is very important because CMT1C is slowly progressive. Early treatment for weakness, contractures (stiff joints), and foot deformities can prevent bigger problems later, such as falls, ulcers, and severe deformities. PMC+2Mayo Clinic+2

---

Non-pharmacological treatments (therapies and other methods)

1. Individualized physical therapy program

A physical therapist builds a personal exercise plan for CMT1C. The program often includes gentle strengthening, stretching, balance training, and endurance exercises like walking or cycling. The goal is to keep muscles working as well as possible without causing over-fatigue. This helps slow loss of strength, maintains joint movement, and reduces risk of falls. Regular sessions teach you safe ways to move, get up from chairs, and walk on uneven ground. Physical therapy is a core part of CMT management across all ages. cmtausa.org+2Physiopedia+2

2. Occupational therapy for hands and daily tasks

Occupational therapists help you manage daily activities like writing, using a keyboard, buttoning clothes, or cooking. They may suggest special grips, adapted cutlery, or writing tools to make tasks easier when hand muscles are weak. They also teach joint-protecting techniques, pacing during the day, and smart ways to organize your home or school desk. The purpose is to keep you independent and safe at school, work, and home, even as symptoms change slowly. cmtausa.org+1

3. Regular stretching and flexibility training

Stretching exercises keep muscles and tendons from becoming short and tight. In CMT1C, ankle and toe muscles are often weak, which can pull joints into abnormal positions and cause contractures. Gentle daily stretching of calves, hamstrings, and feet helps maintain joint range of motion and may slow deformity. It also improves comfort and walking pattern. A therapist teaches safe stretches so you do not overstretch or damage weak muscles or ligaments. Mayo Clinic+1

4. Aerobic (cardio) exercise

Low-impact aerobic exercise, such as swimming, cycling, or brisk walking, can improve heart and lung fitness, mood, and overall stamina without putting too much stress on weak feet. In CMT, controlled endurance training has been shown to improve function and ability to do daily activities, as long as it is supervised and increased slowly. The purpose is to fight fatigue, help weight control, and support long-term health. PMC+2ScienceDirect+2

5. Strength and resistance training

Carefully planned resistance exercise helps preserve muscle strength near the shoulders and hips and sometimes in less affected leg muscles. Light weights, resistance bands, or body-weight exercises can be used. The aim is not bodybuilding, but maintaining function. Overly heavy training may over-stress weak nerves and muscles, so intensity is kept low to moderate and supervised by a therapist who understands CMT. PMC+2Pod NMD+2

6. Balance and proprioception training

CMT1C often reduces sensation in the feet, so your brain receives less information about where your feet are. Special balance exercises, like standing on foam, heel-to-toe walking, or using balance boards under supervision, train the nervous system to use vision and remaining sensation more effectively. The purpose is to reduce falls, improve confidence, and allow safer walking on uneven surfaces. PMC+2Pod NMD+2

7. Ankle-foot orthoses (AFOs)

AFOs are custom braces that support the ankle and foot. They help lift the front of the foot (foot drop), prevent tripping, and improve walking pattern. AFOs can be rigid or flexible depending on weakness and deformity. They reduce energy use when walking and may lower pain and risk of ankle sprain. Many people with CMT need AFOs at some point to stay independent in walking longer distances. LER Magazine+3cmtausa.org+3www.slideshare.net+3

8. Custom footwear and shoe inserts

Orthopedic shoes and insoles are used to give the foot a stable base when arches collapse or toes claw. Extra-depth shoes allow room for deformities and braces. Shock-absorbing insoles may reduce pain when walking. Good footwear spreads pressure evenly, preventing calluses and ulcers on areas with less feeling. This is important for long-term foot protection in CMT1C. PubMed+1

9. Hand splints and wrist supports

Soft or rigid splints can support weak hand or wrist muscles. They help keep joints in better position, making it easier to grip objects, write, or type. Night splints may prevent joints from curling and becoming stiff. Wrist supports can also reduce strain and pain. These devices are often used together with hand exercises taught by occupational therapists. cmtausa.org+1

10. Pain management with non-drug methods

Non-drug pain options include heat packs, cold packs, gentle massage, and sometimes TENS (a small battery device that sends mild electrical pulses to the skin). Relaxation techniques, breathing exercises, and mindfulness can also reduce how strongly the brain “feels” pain. The purpose is to lower chronic discomfort without adding drug side effects. These methods are often used along with medicines, not instead of them. cmtausa.org+2PMC+2

11. Cognitive behavioral therapy (CBT) for chronic pain

CBT is a talking therapy that helps you change unhelpful thoughts and behaviors related to long-term pain or disability. It does not say “the pain is not real.” Instead, it teaches skills to cope better with pain, reduce fear of movement, and improve mood and sleep. In neuropathic pain conditions, CBT is one of the best studied psychological treatments and can be very helpful alongside medical care. cmtausa.org+1

12. Energy conservation and fatigue management

Many people with CMT1C feel tired because walking and hand tasks require extra effort. Occupational therapists teach “work-simplifying” methods, such as sitting while doing tasks, using wheeled bags instead of carrying heavy loads, planning rests between activities, and organizing rooms to reduce walking distance. These strategies let you save energy for the most important parts of your day, such as school or work. cmtausa.org+1

13. Assistive devices for mobility

Canes, crutches, walkers, or occasionally wheelchairs may be used when balance or leg strength is limited. The purpose is not to “give up,” but to prevent falls, injuries, and fatigue so you can still join activities. Using a device often increases independence rather than reducing it. A therapist will match the device to your needs and train you in safe use. PMC+1

14. Home and school safety modifications

Simple changes like removing loose rugs, adding grab bars, improving lighting, and keeping cables off the floor can lower fall risk at home. At school, ramps, elevators, extra time between classes, or locker placement can make movement easier. These environmental changes protect you from accidents that could cause fractures or serious injuries. PMC+1

15. Podiatry and skin care

Because sensation in the feet is reduced, you may not feel small injuries. Regular podiatry visits help keep nails, calluses, and skin in good condition. The podiatrist can trim nails safely, treat corns, and watch for pressure areas that might turn into ulcers. Daily self-inspection of feet, with help from family if needed, is also important. nhs.uk+2PubMed+2

16. Genetic counseling

A genetic counselor explains how CMT1C is passed in families, the chance of children inheriting it, and what genetic tests can show. This can be important when planning a family later in life. Counseling can also help you understand the difference between CMT1C and other neuropathies, so you do not confuse it with immune or toxic nerve damage. MalaCards+2cmtausa.org+2

17. Education about neurotoxic drugs and lifestyle risks

Some drugs and toxins can damage nerves further. Chemotherapy agents like vincristine and certain other medicines may worsen neuropathy. People with CMT are usually advised to avoid known neurotoxic drugs when possible and to limit heavy alcohol use. Learning about these risks helps you and your doctors make safer choices. Muscular Dystrophy Association+2Charcot-Marie-Tooth Disease+2

18. Psychological support and support groups

Living with a lifelong condition can cause sadness, anxiety, or social isolation. Talking with a psychologist, counselor, or social worker lets you express fears and learn coping skills. Support groups, including online groups for CMT, help you meet others with similar problems, share tips, and feel less alone. Good mental health supports better physical health and treatment success. cmtausa.org+2Charcot-Marie-Tooth Disease+2

19. School and workplace accommodations

Teachers and employers can help by allowing extra time for walking between rooms, using lifts instead of stairs, flexible seating, ergonomic keyboards, or permission to rest during long standing tasks. Laws in many countries protect the rights of people with disabilities at school and work. Proper accommodations reduce stress on nerves and joints and keep you active in education and employment. PMC+2ScienceDirect+2

20. Long-term multidisciplinary follow-up

The best care for CMT1C usually involves a team: neurologist, physical therapist, occupational therapist, orthopedic surgeon, podiatrist, genetic counselor, and sometimes pain specialist and psychologist. Regular visits allow early detection of new problems, such as worsening deformity or pain, so they can be treated before they cause permanent damage. Long-term team care is the backbone of effective CMT management. PMC+2ScienceDirect+2

---

Drug treatments

Very important: Drug information below is general and mainly based on FDA prescribing information and CMT pain literature. It is not a treatment plan. Dosing and choices must be made only by a doctor who knows the patient. Never start or change medicines by yourself. FDA Access Data+5PMC+5Medscape+5

Because there is no approved drug that corrects the LITAF gene or directly reverses CMT1C, medicines are used to control pain, cramps, mood problems, and other symptoms.

I will keep each description compact so everything fits in your requested length, but still explain class, general adult dosing pattern, purpose, main mechanism, and key side effects.

1. Acetaminophen (paracetamol – non-opioid analgesic)

Acetaminophen is often the first medicine used for mild musculoskeletal pain in CMT, such as aches from overworked muscles and joints. It works mainly in the brain by reducing pain signals and fever, but it does not reduce inflammation like NSAIDs. Typical adult doses are up to 3,000 mg per day in divided doses, but doctors may choose lower limits for safety. Side effects are usually mild at proper doses, but liver damage can occur with overdose or heavy alcohol use. PMC+1

2. Ibuprofen (NSAID pain reliever)

Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used for joint pain, inflammation, and mild to moderate musculoskeletal pain. It reduces prostaglandin production by blocking COX enzymes, which lowers pain and swelling. Adults often take 200–400 mg every 6–8 hours, but total daily dose and duration are set by the physician. Main risks are stomach irritation, ulcers, kidney strain, and higher blood pressure when used long term or at high doses. PMC+1

3. Naproxen (longer-acting NSAID)

Naproxen is another NSAID that lasts longer than ibuprofen, so it is sometimes preferred for persistent joint or back pain linked to abnormal walking. It works with the same COX-blocking mechanism. Adults may use doses such as 250–500 mg twice daily, within total limits defined in the label and by the doctor. Side effects are similar to other NSAIDs: stomach irritation, bleeding risk, kidney problems, and possible cardiovascular risk with long-term use. PMC+1

4. Gabapentin (antiepileptic, used for neuropathic pain)

Gabapentin is an anti-seizure drug widely used off-label or on-label for neuropathic pain, such as burning, tingling, and electric-shock sensations in CMT. It binds to calcium channel subunits in nerve cells and reduces abnormal pain signaling. Typical adult doses range from 900–3,600 mg/day in divided doses, slowly increased to limit drowsiness and dizziness. The FDA label warns about sleepiness, dizziness, weight gain, and rare mood or suicidal thoughts. FDA Access Data+4PMC+4Medscape+4

5. Pregabalin (LYRICA – antiepileptic for neuropathic pain)

Pregabalin is closely related to gabapentin and is FDA-approved for several neuropathic pain conditions. It reduces the release of pain-related neurotransmitters by binding to calcium channels. For neuropathic pain in adults, common total daily doses range around 150–300 mg, sometimes higher, divided into two or three doses, titrated as tolerated. Side effects include dizziness, sleepiness, weight gain, swelling in the legs, and possible mood changes. It is a controlled substance because of misuse risk. FDA Access Data+6PMC+6Medscape+6

6. Duloxetine (SNRI antidepressant for neuropathic pain)

Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) approved for diabetic neuropathic pain and other pain syndromes. It is sometimes used by neurologists for neuropathic pain in hereditary neuropathies like CMT. It increases serotonin and norepinephrine in pain-modulating pathways in the brain and spinal cord. Typical adult doses are 30–60 mg once daily. Side effects may include nausea, dry mouth, sleepiness or insomnia, sweating, and small changes in blood pressure. FDA Access Data+5PMC+5Medscape+5

7. Amitriptyline (tricyclic antidepressant)

Amitriptyline is an older antidepressant often used in low doses for neuropathic pain and sleep problems. It blocks reuptake of serotonin and norepinephrine and also affects other receptors that change how pain is perceived. Doctors may start adults at 10–25 mg at night and increase slowly. Common side effects are dry mouth, constipation, blurred vision, weight gain, and drowsiness; in some people with CMT it may worsen fatigue or balance, so monitoring is important. PMC+2Charcot-Marie-Tooth Disease+2

8. Nortriptyline (tricyclic antidepressant, better tolerated for some)

Nortriptyline is related to amitriptyline but often causes slightly fewer sedating and anticholinergic side effects. It is used similarly for neuropathic pain, starting at low doses such as 10–25 mg at night. It works by enhancing serotonin and norepinephrine signaling in descending pain control pathways. Side effects can include dry mouth, constipation, dizziness, and heart rhythm changes at higher doses, so ECG monitoring may be needed in some patients. PMC+1

9. Venlafaxine (SNRI class)

Venlafaxine is another SNRI that can be used off-label for neuropathic pain when other medicines do not work or cause side effects. It increases serotonin and norepinephrine in the brain. Adult doses vary widely (for example 75–225 mg/day), adjusted by the physician. Side effects include nausea, insomnia, sweating, increased blood pressure at higher doses, and withdrawal symptoms if stopped abruptly, so tapering is necessary. PMC+1

10. Lidocaine 5% medicated patch

Lidocaine patches deliver a local anesthetic through the skin over painful areas, such as a very sensitive part of the foot. They block sodium channels in small nerve fibers and reduce pain signal transmission. Patches are usually worn for limited hours per day according to the label. Systemic side effects are low if used as directed, but skin irritation or numbness may occur. They are especially useful when pain is localized. cmtausa.org+2PMC+2

11. Capsaicin topical preparations

Capsaicin cream or patches use an extract from chili peppers to “desensitize” pain fibers in the skin by acting on TRPV1 receptors. After an initial burning or warm feeling, repeated use reduces neuropathic pain. Over-the-counter low-dose creams are applied several times per day; stronger patches are applied less often by trained staff. Side effects are mainly local burning or redness. Care is needed to avoid eye contact. cmtausa.org+1

12. Tramadol (weak opioid + serotonin/norepinephrine effects)

Tramadol is a centrally acting pain medicine used for moderate pain when non-opioid options fail. It binds weakly to opioid receptors and also blocks serotonin and norepinephrine reuptake. Adult doses and schedules strictly follow label and doctor guidance. Side effects include nausea, dizziness, constipation, drowsiness, seizure risk, and serious breathing problems at high doses or in sensitive people. Because of dependence and overdose risk, it is used cautiously and usually only for short periods. FDA Access Data+8PMC+8Medscape+8

13. Short-acting stronger opioids (rare, severe cases only)

In very severe pain crises, stronger opioids might be used briefly in hospital settings. They act directly on opioid receptors in the brain and spinal cord to blunt pain perception. Because of high risk of dependence, overdose, constipation, hormonal effects, and respiratory depression, most experts try to manage CMT pain with non-opioid and neuropathic agents instead. Use is highly restricted and monitored. PMC+2Medscape+2

14. Baclofen (muscle relaxant)

Baclofen is a GABA-B receptor agonist that reduces spasticity and muscle cramps by acting on the spinal cord. In CMT, it may help troublesome leg cramps or stiffness. Adult doses are started low (for example 5–10 mg three times daily) and increased carefully. Side effects include sleepiness, weakness, dizziness, and, with sudden stop after high doses, withdrawal symptoms. It must be used cautiously in people who are already weak. PMC+1

15. Tizanidine (α2-agonist muscle relaxant)

Tizanidine reduces muscle tone by acting on α2 receptors in the central nervous system. It can help with painful muscle tightness and spasms. Typical adult dosing starts low and is slowly increased. Common side effects are drowsiness, dry mouth, and low blood pressure. The drug can affect liver function, so doctors may check liver tests for people on long-term therapy. PMC+1

16. Low-dose benzodiazepines (for severe nighttime cramps or anxiety – very cautious use)

In certain resistant cases, small doses of medicines like clonazepam may be used at night to ease muscle jerks or intense anxiety related to chronic illness. They work by enhancing GABA, the main calming neurotransmitter in the brain. They can cause drowsiness, dependence, memory problems, and worsen balance, so long-term use is generally avoided or very carefully supervised. PMC+1

17. SSRIs (e.g., sertraline) for depression/anxiety

Living with chronic pain and disability can cause depression or anxiety. Selective serotonin reuptake inhibitors (SSRIs), such as sertraline, increase serotonin in the brain and help stabilize mood. They are not direct treatments for neuropathic pain but can improve coping, sleep, and overall quality of life. Doses vary by drug and person. Side effects can include nausea, headache, sleep changes, and sexual side effects. PMC+2Medscape+2

18. Sleep medicines in carefully selected cases

Severe neuropathic pain sometimes prevents sleep. Doctors may use short-term sedative medicines or melatonin to improve sleep. Better rest can reduce pain perception and fatigue. Because many sleep drugs can worsen balance and cause morning drowsiness, they are used with caution, especially in anyone who is at risk of falls. Non-drug sleep hygiene is usually tried first. cmtausa.org+2PMC+2

19. Vitamin replacement when true deficiency is present

If blood tests show low levels of vitamin B12, folate, vitamin D, or other nutrients, doctors may prescribe replacement tablets or injections. Correcting deficiency does not cure the genetic neuropathy, but it prevents extra damage from treatable causes of nerve dysfunction. Doses depend on the specific deficiency and follow standard guidelines. PMC+2Medscape+2

20. Medicines for associated conditions (e.g., blood pressure, diabetes)

If a person with CMT1C also has diabetes, high blood pressure, or high cholesterol, correct treatment of these conditions protects blood vessels and nerves. For example, good diabetes control reduces additional peripheral nerve damage. The specific drugs (such as insulin or blood-pressure medicines) are chosen according to general medical guidelines, not because of CMT itself, but they are vital to overall nerve health. PMC+2Medscape+2

---

Dietary molecular supplements

Supplements should never replace a balanced diet or prescribed treatment. Evidence in CMT is limited; most data come from studies in other neuropathies. Always discuss with your doctor before starting any supplement.

1. Vitamin B12

Vitamin B12 is essential for myelin and nerve function. True deficiency can cause neuropathy and should always be corrected. In people with CMT1C, B12 supplements are mainly used if blood levels are low. Oral doses often range from 250–1,000 mcg daily, or periodic injections if absorption is poor. It supports normal nerve conduction, but it does not fix the genetic LITAF defect. PMC+2Medscape+2

2. B-complex vitamins (B1, B6, B12)

Balanced B-group vitamins support nerve metabolism and energy production. B1 and B6 play roles in nerve conduction and neurotransmitter production. Moderate doses in combined tablets are sometimes used in neuropathy care, but mega-doses of B6 can actually damage nerves, so dose control is crucial. The goal is to correct possible mild deficiencies and support general nerve health rather than to cure CMT1C. PMC+2Medscape+2

3. Folate (folic acid)

Folate helps in DNA synthesis and repair and in making red blood cells. Low folate may worsen fatigue and indirectly harm nerves. Supplementation is used when deficiency is proven, often 0.4–1 mg daily, under medical guidance. In CMT1C, folate has no specific gene-level effect, but it improves overall health and may help prevent additional neuropathy from deficiency. Wikipedia

4. Vitamin D

Vitamin D supports bone health, muscle function, and immune balance. People with limited mobility often have low vitamin D because they get less sunlight. Replacement doses depend on blood level and local guidelines. Adequate vitamin D may reduce fracture risk from falls and improve muscle performance slightly but does not change the course of CMT1C. PMC+2Medscape+2

5. Omega-3 fatty acids (fish oil)

Omega-3 fats from fish oil have anti-inflammatory effects and may benefit cardiovascular and brain health. Some studies suggest they may help general nerve health, but evidence in CMT is weak. Typical supplemental doses are about 1–2 g/day of EPA+DHA, adjusted by the doctor. They can thin the blood slightly, so they must be used cautiously with blood-thinning drugs. PMC+1

6. Alpha-lipoic acid

Alpha-lipoic acid is an antioxidant used in some countries for diabetic neuropathy. It helps reduce oxidative stress in nerves and may improve pain or numbness in some people with metabolic neuropathy. Oral doses used in studies are often around 600 mg/day. In CMT, evidence is limited, so doctors may or may not recommend it. Side effects can include stomach upset and low blood sugar in susceptible people. PMC+1

7. Coenzyme Q10

CoQ10 is involved in mitochondrial energy production. It has been tested in some mitochondrial and neuromuscular disorders with mixed results. Usual doses are 100–300 mg/day, but regimens vary. The idea is to support energy availability in muscles and nerves. Side effects are usually mild, such as stomach discomfort. There is no strong proof it changes CMT1C progression, so it should be seen as supportive, not curative. PMC+1

8. Magnesium

Magnesium helps with muscle relaxation and nerve transmission. Supplements may reduce night cramps or muscle twitching in some people. Typical oral doses are 200–400 mg/day, taken with food. Too much magnesium can cause diarrhea and, in kidney disease, serious problems, so medical oversight is needed. In CMT1C, it is used symptomatically, not as a disease-targeting therapy. PMC+1

9. Antioxidant vitamins C and E

Vitamins C and E protect cells from oxidative stress. While they support overall health, there is little direct evidence that they modify hereditary neuropathies. They are usually obtained through a diet rich in fruits, vegetables, nuts, and seeds; low-dose supplements may be used in deficiency. Very high doses can have side effects or interact with other medicines. PMC+2Medscape+2

10. L-carnitine

L-carnitine is involved in fatty-acid transport into mitochondria for energy. Some neuromuscular conditions show low carnitine levels. Supplement doses vary (for example, 500–2,000 mg/day in adults under medical supervision). It may help fatigue in some people but has limited evidence in CMT1C. Side effects can include stomach upset and a fishy body odor. PMC+1

---

Regenerative, immune-related and stem-cell-type therapies

1. Gene-targeted therapies for CMT1C (research stage)

Scientists are studying how LITAF/SIMPLE mutations damage myelin and whether gene therapy could correct this defect. Experimental strategies may include viral vectors delivering healthy gene copies or methods that adjust how the faulty gene is expressed. These treatments are still in pre-clinical or early research stages and are not available as routine care. Participation in well-regulated clinical trials is the only safe way to access such therapies if they become available. MalaCards+4molbiolcell.org+4PLOS+4

2. Neurotrophic factor therapies (research)

Neurotrophins, such as nerve growth factor (NGF) or neurotrophin-3, support neuron survival and myelin health. Trials in other neuropathies have explored using these molecules or drugs that increase their levels. The idea is to help damaged nerves repair or stabilize. However, side effects and limited benefit have been problems, and no neurotrophic therapy is approved for CMT1C. They remain an experimental concept. PMC+2ScienceDirect+2

3. Stem cell therapies for peripheral nerve repair (experimental)

Researchers are testing whether stem cells, such as mesenchymal stem cells, can support nerve regeneration or provide growth factors in damaged nerves. In animal models of peripheral neuropathy, some improvement in myelin and axons has been seen, but human data in hereditary neuropathy are still very limited. There is currently no approved stem cell treatment for CMT1C. Any clinic offering “guaranteed cures” with stem cells should be viewed with extreme caution. PMC+2ScienceDirect+2

4. Small-molecule modulators of protein handling (research)

Because LITAF is involved in protein degradation and endosomal function, scientists are exploring drugs that improve protein processing and prevent build-up of misfolded proteins. These approaches may use small molecules that modify cellular stress responses or enhance autophagy. This work is at an early laboratory stage, not clinical practice, but it may offer future “disease-modifying” options. ScienceDirect+3molbiolcell.org+3PLOS+3

5. Immune therapies (rarely relevant, mostly for misdiagnosed cases)

CMT1C is a genetic demyelinating neuropathy, not an autoimmune disease. Immune therapies like intravenous immunoglobulin (IVIG) or steroids are not standard for pure CMT1C. However, if someone has both CMT and a separate immune neuropathy, doctors may use immune drugs for the immune part. This is uncommon and must be guided by specialist nerve conduction studies and sometimes nerve biopsy. PMC+2ScienceDirect+2

6. General immunity support (vaccination and healthy lifestyle)

While not a drug “for CMT1C,” routine vaccines (such as influenza and pneumonia where indicated), good sleep, stress management, and balanced nutrition help the immune system work well and reduce infections. Fewer infections can mean fewer periods of inactivity, less deconditioning, and better long-term function. This is a practical way to support resilience, even if it does not change the gene defect. PMC+1

---

Surgical options

1. Foot deformity correction (osteotomy, soft-tissue balancing)

Long-standing muscle imbalance can cause high arches (pes cavus), claw toes, and hammertoes. Orthopedic surgeons can cut and realign bones (osteotomy) and adjust tendons to rebalance the foot. The main goals are to improve foot shape, allow better shoe fitting, reduce pain and calluses, and improve walking stability. Surgery is usually considered when braces and shoes no longer provide enough support. PubMed+3PMC+3ScienceDirect+3

2. Tendon transfer procedures

In tendon transfer surgery, a stronger muscle’s tendon is moved to help a weaker movement, such as lifting the front of the foot. For example, a functioning tendon can be rerouted to improve dorsiflexion and reduce foot drop. This can reduce tripping and dependence on AFOs. Decisions depend on which muscles are still relatively strong and on the overall pattern of deformity. ScienceDirect+2LER Magazine+2

3. Ankle fusion (arthrodesis)

In severe deformity with pain and instability, the ankle joint may be fused so that bones grow together in a corrected position. This removes motion at that joint but can create a stable, plantigrade (flat) foot that fits in shoes and reduces pain. It is usually a last-line option when other surgeries and bracing cannot provide stability. ScienceDirect+1

4. Spine surgery for scoliosis (if present)

Some people with CMT develop spinal curvature (scoliosis), especially if weakness is uneven between sides. When scoliosis is severe or progressing, spinal fusion with rods and screws may be recommended to stabilize the spine, reduce pain, and prevent breathing problems. This is more common in other neuromuscular conditions but can be part of CMT care in selected cases. PMC+2ScienceDirect+2

5. Nerve decompression procedures (selective and controversial)

In a few situations, tight tunnels (like the carpal tunnel in the wrist) can compress already vulnerable CMT nerves, causing extra symptoms. Surgeons may perform decompression to relieve pressure. However, results in hereditary neuropathy are mixed, and the decision is complex. Surgery is usually reserved for clear compression on tests plus disabling symptoms not controlled by conservative methods. PMC+2ScienceDirect+2

---

Prevention and lifestyle tips

Because CMT1C is genetic, you cannot prevent the disease itself, but you can prevent or delay many complications:

1. Avoid known neurotoxic drugs where possible (for example, vincristine and some others your neurologist will list). Muscular Dystrophy Association+2Charcot-Marie-Tooth Disease+2

2. Limit or avoid heavy alcohol use, which can damage nerves further. Muscular Dystrophy Association+1

3. Keep a healthy weight to reduce stress on weak feet, ankles, and knees. PMC+2nhs.uk+2

4. Exercise regularly but gently with guidance from a therapist, avoiding over-fatigue. PMC+2Mayo Clinic+2

5. Protect your feet with good footwear, daily inspection, and early care of blisters or calluses. nhs.uk+2PubMed+2

6. Do regular stretching to prevent contractures around ankles, knees, and hips. Mayo Clinic+2nhs.uk+2

7. Stop smoking, because smoking decreases blood flow to nerves and muscles. PMC+2Medscape+2

8. Treat other diseases well, especially diabetes or thyroid disease, to avoid additional nerve damage. PMC+2Medscape+2

9. Use braces and aids early when recommended, rather than waiting until falls or injuries occur. Charcot-Marie-Tooth Disease+3cmtausa.org+3Pod NMD+3

10. Attend regular follow-up visits with specialist teams to adjust treatment as your body changes. PMC+2ScienceDirect+2

---

When to see doctors

You should see your neurologist, pediatrician, or family doctor (and tell your parents) if:

• You notice new or rapidly worsening weakness, especially if you suddenly cannot lift your foot or hand as before. PubMed+2Cureus+2

• You have frequent falls, ankle sprains, or feel very unsteady on familiar surfaces.

• You see new foot deformities or your shoes no longer fit because of shape changes. PMC+2ScienceDirect+2

• You develop numbness, burning, or electric-shock pain that is new or much worse than before. PMC+2Medscape+2

• You notice sores, ulcers, or color changes on your feet that do not heal quickly. nhs.uk+2PubMed+2

• You have breathing trouble, swallowing problems, or chest deformity (rare in CMT1C but important to check). PMC+2ScienceDirect+2

• You feel very sad, hopeless, or anxious for many days, or have sleep problems because of pain or worry. cmtausa.org+2Charcot-Marie-Tooth Disease+2

Emergency services should be called if you have severe breathing difficulty, chest pain, or thoughts of harming yourself or others.

---

What to eat and what to avoid

1. Eat plenty of colorful vegetables and fruits. They provide vitamins, minerals, and antioxidants that support general health, immunity, and tissue repair. PMC+1

2. Choose lean proteins like fish, poultry, beans, and lentils to support muscle maintenance and healing. Oily fish also add omega-3 fats. PMC+1

3. Include whole grains (brown rice, whole-wheat bread, oats) for steady energy and fiber, which help manage weight and blood sugar.

4. Use healthy fats from olive oil, nuts, and seeds rather than fried foods or trans fats. This supports heart and nerve health.

5. Get enough calcium and vitamin D through dairy or fortified plant milks, plus safe sunlight exposure or supplements if prescribed. This keeps bones strong in case of falls. PMC+2Medscape+2

6. Drink plenty of water and avoid sugary drinks to maintain good circulation and weight control.

7. Limit sugary and ultra-processed foods, which cause weight gain and may worsen inflammation and fatigue.

8. Avoid heavy alcohol use, which can directly damage nerves and interact with pain medicines. Muscular Dystrophy Association+2Medscape+2

9. Do not use mega-dose supplements without medical advice. Extra-high doses of some vitamins (like B6) can be toxic to nerves. PMC+2Medscape+2

10. Match food to your activity level, working with a dietitian if possible, to keep a healthy weight that protects your joints and feet. PMC+2nhs.uk+2

---

Frequently asked questions

1. Is CMT1C curable?

No. At present there is no cure that can remove or repair the LITAF gene mutation in CMT1C. Treatments focus on symptoms, function, and preventing complications. Research is ongoing in gene therapy and other disease-modifying options, but these are not yet routine care. American Academy of Neurology+3PubMed+3molbiolcell.org+3

2. Will everyone with CMT1C end up in a wheelchair?

Not usually. Studies suggest CMT1C often causes milder weakness than some other CMT types, and many people remain able to walk, especially with braces and therapy. However, progression varies between individuals, so regular follow-up and early treatment are still important. MalaCards+3PubMed+3Cureus+3

3. Is exercise safe if I have CMT1C?

Yes, when it is supervised and adapted to your abilities. Gentle aerobic, strengthening, and stretching exercises are generally safe and helpful. Over-intense training that causes extreme fatigue or pain should be avoided. A physical therapist familiar with CMT can design the right plan for you. Journal of Health and Allied Sciences NU+3PMC+3Mayo Clinic+3

4. Do braces mean my disease is getting worse?

Using braces like AFOs does not mean you have failed. They are tools to keep you walking safely and longer. Many people with CMT improve their independence and confidence once they start using braces. The decision to use them is based on function and safety, not only on disease severity. Charcot-Marie-Tooth Disease+3cmtausa.org+3Pod NMD+3

5. Are there special shoes for CMT1C?

Yes. Orthopedic or extra-depth shoes, sometimes with custom insoles, help support the arches, reduce pressure points, and fit braces. They can reduce pain and prevent ulcers. A podiatrist or orthotist can help choose suitable footwear based on your foot shape and walking pattern. nhs.uk+2PubMed+2

6. Which pain medicine is “best” for CMT1C?

There is no single “best” medicine. Mild pain might respond to acetaminophen or NSAIDs, while neuropathic pain often needs medicines like gabapentin, pregabalin, or duloxetine. The right choice depends on pain type, other health problems, age, and response to treatment. Your doctor usually starts with lower-risk options and adjusts over time. FDA Access Data+5PMC+5Medscape+5

7. Can pain medicines stop the disease from progressing?

No. Pain medicines help you feel better and function better, but they do not slow or stop the underlying CMT1C process. This is why non-drug measures (exercise, braces, lifestyle changes) and future research on disease-modifying therapies are so important. Wikipedia+3PMC+3PMC+3

8. Are stem cell clinics on the internet safe for CMT1C?

Most commercial clinics offering “stem cell cures” for CMT are not supported by strong research and may be unsafe or extremely expensive. At present, stem cell therapy for CMT1C is experimental and should be done only in properly regulated clinical trials. Always discuss such offers with a neurologist and check whether trials are approved by recognized ethics boards. PLOS+3PMC+3ScienceDirect+3

9. Is CMT1C the same as CMT1A?

No, but they are related. Both are demyelinating forms of CMT type 1, but they involve different genes. CMT1A usually involves duplication of PMP22, while CMT1C involves mutations in LITAF. Clinical features can overlap, and some CMT1C cases resemble mild CMT1A, but the genetic causes are distinct. Wikipedia+4PubMed+4cmtausa.org+4

10. Can I have children if I have CMT1C?

Yes, many people with CMT1C have children. However, CMT1C is usually inherited in an autosomal-dominant pattern, meaning each child has a 50% chance of inheriting the mutation. Genetic counseling can explain options such as prenatal diagnosis or assisted reproduction techniques if desired in adulthood. MalaCards+2cmtausa.org+2

11. Does diet alone treat CMT1C?

No diet can cure CMT1C. However, healthy eating supports muscle strength, weight control, bone health, and overall energy levels, which all affect how well you manage the disease. Avoiding alcohol and severe vitamin deficiencies also protects nerves from extra harm. PMC+2Medscape+2

12. Can CMT1C affect my breathing?

Most people with mild CMT1C never have breathing problems. In severe or long-standing CMT or in other types, weakness of respiratory muscles can occur. If you notice shortness of breath, especially at night or on exertion, you should tell your doctor so they can check lung function. PMC+2ScienceDirect+2

13. Will school sports always be impossible for me?

Not necessarily. Many people with CMT1C can join low-impact sports or adapted physical activities, especially with good braces and guidance. You may not be able to safely do high-impact contact sports, but swimming, cycling, and some gym activities are often fine. Work with your doctor and PE teachers to adapt your sports plan. Journal of Health and Allied Sciences NU+3PMC+3Mayo Clinic+3

14. How often should I see my neurologist?

Frequency depends on age and severity, but many people see a neurologist yearly or every couple of years, and more often during periods of change or before surgeries. Children and teenagers may need closer follow-up as they grow, to adjust braces, exercises, and school supports. PMC+2ScienceDirect+2

15. What can I do today to protect my future with CMT1C?

Today you can start simple habits: stretch daily, use safe footwear, stay active with gentle exercise, protect your feet, avoid smoking and heavy alcohol, keep a healthy weight, and talk openly with your family and doctors about any new symptoms. These steps, repeated over years, can make a big difference to your long-term independence and quality of life. Wikipedia+5PMC+5Mayo Clinic+5

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 25, 2025.